FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely pharmacology. A pharmaceutical composition contains an active component selected from a group of pharmacologically active substances: having an effect on a central nervous system, peripheral neurotransmitter processes, cardiovascular system, coagulation system, neoplastic processes, metabolic processes, showing antibacterial activity, an excipient, cyclodextrin as a component ensuring high bioavailability, and a component modulating a duration of the pharmacologically active substance representing polymer. The pharmaceutical composition is presented in the form of a powder of particle size within 0.4 to 2 mcm. A method for administration of the pharmaceutical composition provides the pulmonary oral administration in the form of a dry or liquid aerosol with mass median aerodynamic diameter 0.8 to 2.0 mcm and degree of polydispersity 0.8 to 2.0.
EFFECT: ensured effective delivery of the pharmacologically active substances in the systemic circulation and alveolar inhalations of min 75% of solid or liquid aerosol particles.
5 cl, 5 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
SINGLE DOSE DRY POWDER INHALER | 2015 |
|
RU2610779C1 |
DIRECTED DELIVERY OF SPRAY-DRIED COMPOSITIONS INTO THE LUNGS | 2016 |
|
RU2731212C2 |
METHOD FOR TREATING ARTERIAL HYPERTENSION BY INHALATION DELIVERY OF HYPOTENSIVE PREPARATION AEROSOL | 2014 |
|
RU2593016C2 |
INHALATION FORMULATION CONTAINING SULFOALKYL ETHER GAMMA-CYCLODEXTRIN AND CORTICOSTEROID | 2004 |
|
RU2390330C2 |
COMBINATION FROM ANTICHOLINERGIC AND STEROID AND ITS APPLICATION FOR TREATMENT OF DISEASES OF RESPIRATORY TRACTS BY INHALATION | 2004 |
|
RU2361586C2 |
INHALATION COMPOSITION CONTAINING SULFOALKYL ETHER | 2004 |
|
RU2388462C2 |
INHALATION MEDICINES CONTAINING BETA-MEMETICS AND ANTICHOLINERGIC AGENT | 2004 |
|
RU2375059C2 |
MEANS FOR TREATING SPASMODIC SYNDROME CASES | 2006 |
|
RU2314828C1 |
Authors
Dates
2012-03-20—Published
2010-05-25—Filed